CD34 and cancer: DCPs from cancer patients including multiple myeloma, acute myeloid leukemia, acute lymphoblastic leukemia, Hodgkin's lymphoma and glioblastoma patients have been successfully generated from a small number of BM CD34+ HPCs over several orders of magnitude ( > 106) (unpublished).